Silencing of IRF8 Mediated by m6A Modification Promotes the Progression of T‐Cell Acute Lymphoblastic Leukemia

T‐cell acute lymphoblastic leukemia (T‐ALL) is an aggressive hematological malignancy with a poor prognosis, urging for novel therapeutic targets and treatment strategies. N6‐methyladenosine (m6A) is a crucial methylation modification that affects the pathogenesis of leukemia by regulating the mRNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ying, Ji, Min, Xia, Yuan, Han, Xiaoyu, Li, Mingying, Li, Wei, Sun, Tao, Zhang, Jingru, Lu, Fei, Sun, Yanping, Liu, Na, Li, Jingxin, Ma, Daoxin, Ye, Jingjing, Ji, Chunyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839875/
https://www.ncbi.nlm.nih.gov/pubmed/36478193
http://dx.doi.org/10.1002/advs.202201724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839875/
https://www.ncbi.nlm.nih.gov/pubmed/36478193
http://dx.doi.org/10.1002/advs.202201724

Ejemplares similares